Tempus AI (NasdaqGS:TEM) has launched a new AI-driven HRD-RNA algorithm aimed at improving cancer diagnostics. The company has entered a partnership with Median Technologies to bring advanced lung ...

Reflecting on Eric Dane’s poignant "final interview," Neal K. Shah shares that the rising "death tech" industry threatens to replace authentic human goodbyes with AI-generated avatars and "digital ...